SlideShare a Scribd company logo
IOSR Journal of Engineering (IOSRJEN) www.iosrjen.org 
ISSN (e): 2250-3021, ISSN (p): 2278-8719 
Vol. 04, Issue 10 (October. 2014), ||V3|| PP 01-06 
International organization of Scientific Research 1 | P a g e 
Mathematical model for Oxytocin alleviates the neuroendocrine in healthy men S.Lakshmi* and M.Gayathri** *Principal, Government Arts & Science College, Peravurani – 614804, Thanjavur – Dt, Tamilnadu. **Research Scholar, P.G and Research Department of Mathematics, K.N. Govt. Arts College for Women (Autonomous), Thanjavur – 613007, Tamilnadu. Abstract: - Maximum Likelihood Estimation is by far the most popular method of parameter estimation and is an indispensable tool for many statistical modeling techniques, in particular in non-linear modeling with non- normal data. The purpose of this paper is to provide a good conceptual explanation of the method with illustrative examples. In application part by using normal distribution the likelihood functions for inflammatory hormone levels in response to endotoxin and plasma concentration oxytocin, ACTH, cortisol, and procalcitonin are obtained. These functions show a clear picture for all the above parameters when LPS+Oxytocin is administered to the inflammatory cases and compared with the medical conclusion. Keywords: Normal distribution, density function, oxytocin. Mathematical subject classification: 60GXX, 62HXX, 62PXX. 1.Mathematical model: 
I. INTRODUCTION 
In the psychological sciences, uncover general laws and principles that govern the behavior under investigation. As these principles are not directly observable, they are formulated in terms of hypotheses. In mathematical modeling, such hypotheses about the structure and inner working of the behavioral process of interest are stated in terms of mathematical functions called models. The goal of modeling is to deduce the form of the underlying process by testing the viability of such models. Once a model is specified with its parameters, data have been collected with specific norms. There are two generally accepted methods of parameter estimation. They are least-squares estimation (LSE) and maximum likelihood estimation (MLE). The former is well known to us as many of the familiar concepts such as linear regression, the sum of squares error, the proportion variance accounted[2] , and the root mean squared deviation are tied to the method. On the other hand, MLE is not widely recognized among modelers in psychology[3], though it is, by far, the most commonly used method of parameter estimation[7]. LSE might be useful for obtaining a descriptive measure for the purpose of summarizing observed data[9], but MLE is more suitable for statistical inference such as model comparison LSE has no basis for constructing confidence intervals or testing hypotheses. 1.2.Maximum Likelihood Estimation The likelihood Function Let X1,……Xn be an i.i.d sample with probability density function (p.d.f) f(xi;θ), where θ is a (k×1) vector of parameters that characterize f(xi;θ)[8]. For example, if Xi~ N(μ,휎2) then f(xi,θ) = (2π휎2)-1/2exp(- 12휎2( xi -μ)2) and θ = (μ,휎2 )ʹ. Then joint density of the sample is, by independence, equal to the product of the marginal densities f(x1,……..xn;θ) = f(x1;θ)……..f(xn;θ) = 푓푛푖 =1(xi,θ). The joint density is an n dimensional function of the data x1……..,xn given the parameter vector θ. The joint density satisfies f(x1,............xn;θ) ≥ 0 ∫…….∫ f(x1…………xn;θ) = 1. The likelihood function is defined as the joint density treated as a functions of the parameters θ : L(θ/x1,……..,xn) = f(x1,………xn;θ) = 푓푛푖 =1(xi,θ). Notice that the likelihood function is a k dimensional function of θ given the data x1,…..xn. It is important to keep in mind that the likelihood function, being a function of θ and not the data, is not a proper p.d.f .It is always positive but ∫……..∫ L(θ/x1……..xn)dθ1………dθk ≠ 1. To simplify notation, let the vector X = (x1,……..xn) denote the observed sample. Then the joint p.d.f and likelihood function may be expressed as f(X;θ) and L(θ/X).
Mathematical model for Oxytocin alleviates the neuroendocrine in healthy men 
International organization of Scientific Research 2 | P a g e 
Example 1 Bernoulli Sampling Let Xi ̴ Bernoulli(θ). That is, Xi = 1 with probability θ and Xi = 0 with probability 1 – θ where 0 ≤ θ ≤ 1. The p.d.f for Xi is xi f(xi;θ) = 휃푥푖 (1−휃)1−푥푖, xi = 0,1 Let X1,…..Xn be an iid sample with Xi ̴ Bernoulli(θ).The joint density/ likelihood function is given by f(x;θ) = L(θ/x) = 휃푥푖푛푖 =1(1−휃)1−푥푖 = 휃 푥푖 푛푖 =1(1−휃)푛− 푥푖 푛푖 =1 For a given value of θ and observed sample x, f(x,θ) gives the probability of observing the sample. For example, suppose n=5 and x = (0,…..,0). Now some values of θ are more likely to have generated this sample than others. In particular, it is more likely that θ is close to zero than one. To see this, note that the likelihood function for this sample is L(θ/(0,…….,0)) = (1-θ)5 The likelihood function has a clear maximum at θ = 0. That is, θ = 0 is the value of θ that makes the observed sample x = (0,……,0) most likely (highest probability) Similarly, suppose x = (1,……..,1). Then the likelihood function is L(θ/(1,……,1)) = θ5 Now the likelihood function has a maximum at θ = 1. Example 2 Normal Sampling Let X1,……….,Xn be an iid sample with Xi ̴ N(μ,휎2). The pdf for Xi is f(xi;θ) = (2π휎2)-1/2exp (- 12휎2 (xi-μ)2), - ∞<휇<∞, 휎2>0, -∞<푥<∞ so that θ = (μ,휎2)ʹ. The likelihood function is given by L(θ/x) = (푛푖 =12π휎2)-1/2exp (- 12휎2 (xi-μ)2), = (2π휎2)-n/2exp (- 12휎2 (푥푛푖 =1i-μ)2) Suppose 휎2 = 1. Then L(θ/x) = L(μ/x) = (2휋)-n/2exp(- 12 (푥푛푖 =1i-μ)2) Now (푥푛푖 =1i-μ)2 = (푥푛푖 =1i - 푥 +푥 -μ)2 = [(푥푛푖 =1i-푥 )2 + 2(xi-푥 )(x-휇 ) + (푥 -μ)2] = (푥푛푖 =1i-푥 )2 + n(푥 -μ)2 So that L(μ/x) = (2π)-n/2exp( - 12 [ (푛푖 =1xi-푥 )2 + n(푥 -μ)2] ) Since both (xi-푥 )2 and (푥 -μ)2 are positive it is clear that L(μ/x) is maximized at μ =푥 . 
II. APPLICATION 
Oxytocin is a hormone and neurotransmitter found to have anti- inflammatory functions in rodents. Ten healthy men received , in a randomized, placebo controlled crossover design, placebo, oxytocin, LPS, and LPS+oxytocin. Oxytocin treatment resultedin a transient or prolonged reduction of endotoxin-induced increase in plasma ACTH, Cortisol, prolactionin.Oxytocin decreases the neuroendocrine and cytokine activation caused by bacterial endotoxin in men. Possibly due to the pathway. Oxytocin –deficient mice exhibit increased stress response associated with a significant hyperactivation of the HPA axis[6]. Here we present a randomized, placebo-controlled, crossover trial, conducted to test the effect of continuous intravenous oxytocin infusion on LPS-induced systemic inflammation in 10 healthy men. In addition, we investigated whether oxytocin directly affects the LPS-induced cytokine release from peripheral blood mononuclear cells (PBMCs) of healthy human donors in vitro. 2.1.Hormone and cytokine measurement. Blood samples were immediately cooled and centrifuged for 10 min at 3.000 rpm, 4ºC, and plasma aliquots were immediately frozen at -20ºC. Plasma oxytocin and ACTH were measured using commercial RIA kits Procalcitonin (PCT) was measured using the BRAHMS Procalcitonin Sensitive LIA kit[5]. All samples taken over the 4 study days for each individual subject were analyzed at the same time and in duplicates. Cell isolation and culture. PBMCs were isolated from acid citrate dextrose buffy coats of healthy donors. CD14_ monocytes were obtained by magnetic cell sorting using anti-CD14-conjugated magnetic microbeads CD14_ monocytes (2 ± 106) or PBMCs (106 cells/ml) were cultured in human serum albumin-containing X- Vivo 10 medium in 12-well plates for 2, 4, and 24 h. Different concentrations of oxytocin (Sigma) or vehicle control (0.1% water) were added to the cells 30 min before adding LPS.
Mathematical model for Oxytocin alleviates the neuroendocrine in healthy men 
International organization of Scientific Research 3 | P a g e 
2.2. Hormone Response Administration of oxytocin elevated within 10 min plasma oxytocin levels (P = 0.021), which reached peak values at time point 60 min (P <0.001) (Fig. 2.2 A). Circulating oxytocin then began to decline 10 min after the infusion was stopped, but remained significantly elevated until time point 120 min (P < 0.001) (Fig. 2.2.A). Plasma concentrations of ACTH (Fig. 2.2.B) and cortisol (Fig. 2.2.C) remained unchanged during oxytocin treatment, but increased after the LPS bolus (P = 0.027 for ACTH at 120 min and P = 0.043 for cortisol at 90 min when comparing LPS vs. placebo). A significantly reduced increase in plasma ACTH was observed at time point 120 min: 36.1 ± 5.9 pg/ml in the LPS ± oxytocin group vs.69.6 ± 14.8 pg/ml in the LPS group (P = 0.019) (Fig. 2.2.B). The LPS-induced increase in plasma cortisol was also alleviated in the LPS ±oxytocin group at time points 90 min (P = 0.03) and 120 min (P = 0.01) (Fig. 2.2.C). To further evaluate the impact of oxytocin on the severity of endotoxinemia, measured the plasma concentrations of PCT, a diagnostic and prognostic biomarker in sepsis [10] Oxytocin significantly reduced the LPS-induced increase in PCT, which presented significant differences at the 240th min (0.178 ± 0.05 ng/ml on LPS days compared with 0.072 ± 0.01 ng/ml on LPS ± oxytocin days, P = 0.043), at the 300th min (P = 0.033), and at the 360th min (P = 0.035) (Fig. 2.3). Consideration the possibility that repeated injections of endotoxin itself may result in an altered immune response, inducing resistance or tolerance in humans. Therefore, the subjects received the four treatments in a randomized order. In addition, we compared the changes in plasma ACTH, cortisol, and PCT between volunteers randomized to receive LPS before the application of LPS ± oxytocin (n = 5) and volunteers randomized to receive LPS ±oxytocin before the administration of LPS (n = 5). Results were similar to those obtained from all volunteers being treated with LPS vs. all volunteers having received LPS ±oxytocin. 
Figure 2.2. Hormone levels in response to endotoxin and oxytocin. Plasma concentrations are shown of oxytocin (A), ACTH (B),and cortisol (C) in response to placebo, oxytocin (1pmol kg -1 min-1 during 90 min. 1=- 10 to 80 min). LPS (2ng/kg iv. i =0 h), and LPS+oxytocin values are means ± SE.
Mathematical model for Oxytocin alleviates the neuroendocrine in healthy men 
International organization of Scientific Research 4 | P a g e 
Figure 2.3.Procalcitonin (PCT) levels in response to endotoxin and oxytocin. Plasma PCT concentrations are shown after placebo or LPS administration (2ng/kg iv. i=0 h), in the presence or absence of oxytocin infusion (t= -10 to 80 min). Values are means ± SE. First, the study population included only healthy men, and we have no data on the role of oxytocin on the LPS-induced endocrine and cytokine activation in women[1]. Second, as this is the first study coadministrating LPS and oxytocin in humans, we took care to use the smallest oxytocin dose needed to achieve elevated oxytocin concentrations during the first 120 min after LPS administration. Nevertheless, the achieved maximal concentrations of 160–180 pg/ml are clearly supraphysiological. Third, LPS administration is only an experimental and self-limiting model of infection and inflammation. In summary, this study demonstrates that pharmacological doses of oxytocin attenuate the endocrine and cytokine activation following bacterial endotoxin administration in humans. Oxytocin appears to modulate innate host defense mechanisms, thereby eventually reducing an LPS-induced overshooting immune response. Mathematical Results 
A. 
0 
0.5 
1 
1.5 
2 
2.5 
3 
3.5 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
L(θ/x) 
x 
Time (1 Unit=30min) 
Likelihood function 
for oxytocin (pg/ml) 
LPS+oxytocin 
oxytocin 
Placebo 
LPS
Mathematical model for Oxytocin alleviates the neuroendocrine in healthy men 
International organization of Scientific Research 5 | P a g e 
B. 
C. 
D. 
Figure (3.1) 
0 
0.2 
0.4 
0.6 
0.8 
1 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
L(θ/x) 
x 
Time (1 Unit=30min) 
Likelihood functionfor 
ACTH (pg/ml) 
LPS 
Placebo 
oxytocin 
LPS+oxytocin 
0 
0.5 
1 
1.5 
2 
2.5 
3 
3.5 
4 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
L(θ/x) 
x 
Time(1 unit =30 min) 
Likelihood function for 
cortisol (pg/ml) 
LPS 
LPS+oxytocin 
oxytocin 
Placebo 
-0.2 
0 
0.2 
0.4 
0.6 
0.8 
1 
1.2 
0 
5 
10 
15 
L(θ/x) 
x 
Time (1unit=30 min) 
Likelihood function for 
PCT (mg/ml) 
oxytocin 
LPS+oxytocin 
LPS
Mathematical model for Oxytocin alleviates the neuroendocrine in healthy men 
International organization of Scientific Research 6 | P a g e 
The figure (3.1),A. indicates that the likelyhood function for oxytocin (pg/ml) is suddenly decreased when LPS+oxytocin is administered. In both the cases the curves are continuous and decreased monotonically with the time axis. Similarly we have obtained the curves for the likelyhood functions for all other categories like ACTH, Cortisol, PCT (if we compare LPS administration cases). These results can be compared with the medical conclusions. This study demonstrates that pharmacological doses of oxytocin attenuate the endocrine and cytokine activation following endotoxin administration in humans. Oxytocin appears to modulate innate host defense mechanism, thereby eventually reducing an LPS induced overshooting immune response. CONCLUSION Maximum Likelihood Estimation is by far the most popular method of parameter estimation and is an indispensable tool for many statistical modeling techniques, in particular in non-linear modeling with non- normal data[4]. The purpose of this paper is to provide a good conceptual explanation of the method with illustrative examples. In application part by using normal distribution the likelihood functions for inflammatory hormone levels in response to endotoxin and plasma concentration oxytocin, ACTH, cortisol, and procalcitonin[10] are obtained. These functions show a clear picture for all the above parameters when LPS+Oxytocin is administered to the inflammatory cases and compared with the medical conclusion. This study demonstrates that pharcological doses of oxytocin attenuate the endocrine and cytokine activation following endotoxin administration in humans. Oxytocin appears to modulate innate host defense mechanism, thereby eventually reducing an LPS induced overshooting immune response. The figure (3.1),A. indicates that the likelyhood function for oxytocin (pg/ml) is suddenly decreased when LPS+oxytocin is administered. In both the cases the curves are continuous and decreased monotonically with the time axis. Similarly we have obtained the curves for the likelyhood functions for all other categories like ACTH, Cortisol, PCT (if we compare LPS administration cases). REFERENCES 
[1] Amico JA, Mantella RC, Wollmer RR, Li X. Anxiety and stress responses in female oxytocin deficient mice. J Neuroendocrinol 16:319–324, 2004 
[2] Bain L.J., Statistical Analysis of Reliability and life testing models ,Marcel Dekker, New York, 1978 
[3] Cohen, A.C.,Jr., Tables for Maximum likelihood estimates; singly truncated and single censored s samples, Technometrices, 3:535-541(1961). 
[4] Consul PC, Shenton LR, Some interesting properties of Lagrangian distributions. Comm. Stat. Theor. Meth: 2, 3, 263 – 272, 1973. 
[5] Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 34: 2596– 2602, 2006. 
[6] Kiriyama Y, Nomura Y, Tokumitsu Y. Calcitonin gene expression induced by lipopolysaccharide in the rat pituitary. Am J Physiol Endocrinol Metab 282: E1380–E1384, 2002. 
[7] Lakshmi S, Gayathri M, Mathematical model for roles of Genital stumilation, intracerebral Oxytocin release. American Journal of pure and applied mathematics. Vol 2, No 2, July-December 2013, 93-98. 
[8] Le Cam, Lucien; Lo Yang, Grace (2000). Asymptotics in Statistics: Some Basic Concepts (second ed.). Springer. ISBN 0-387-95036-2. 
[9] Pfanzagl, Johann (1994). Parametric statistical theory. with the assistance of R. Hamböker. Berlin, DE: Walter de Gruyter. pp. 207–208.ISBN 3-11-013863-8 
[10] Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for Med sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care34: 1996–2003, 2006.

More Related Content

Similar to A041030106

Statistical analysis by iswar
Statistical analysis by iswarStatistical analysis by iswar
E45021924
E45021924E45021924
E45021924
IJERA Editor
 
Taller 2
Taller 2Taller 2
Taller 2
Elizabeth Duque
 
Use Proportional Hazards Regression Method To Analyze The Survival of Patient...
Use Proportional Hazards Regression Method To Analyze The Survival of Patient...Use Proportional Hazards Regression Method To Analyze The Survival of Patient...
Use Proportional Hazards Regression Method To Analyze The Survival of Patient...
Waqas Tariq
 
Matching Weights to Simultaneously Compare Three Treatment Groups: a Simulati...
Matching Weights to Simultaneously Compare Three Treatment Groups: a Simulati...Matching Weights to Simultaneously Compare Three Treatment Groups: a Simulati...
Matching Weights to Simultaneously Compare Three Treatment Groups: a Simulati...
Kazuki Yoshida
 
Computational Pool-Testing with Retesting Strategy
Computational Pool-Testing with Retesting StrategyComputational Pool-Testing with Retesting Strategy
Computational Pool-Testing with Retesting Strategy
Waqas Tariq
 
Bayesian inference for mixed-effects models driven by SDEs and other stochast...
Bayesian inference for mixed-effects models driven by SDEs and other stochast...Bayesian inference for mixed-effects models driven by SDEs and other stochast...
Bayesian inference for mixed-effects models driven by SDEs and other stochast...
Umberto Picchini
 
Fv3410771081
Fv3410771081Fv3410771081
Fv3410771081
IJERA Editor
 
3 es timation-of_parameters[1]
3 es timation-of_parameters[1]3 es timation-of_parameters[1]
3 es timation-of_parameters[1]
Fernando Jose Damayo
 
Causal Inference Opening Workshop - Some Applications of Reinforcement Learni...
Causal Inference Opening Workshop - Some Applications of Reinforcement Learni...Causal Inference Opening Workshop - Some Applications of Reinforcement Learni...
Causal Inference Opening Workshop - Some Applications of Reinforcement Learni...
The Statistical and Applied Mathematical Sciences Institute
 
Survival analysis 1
Survival analysis 1Survival analysis 1
Survival analysis 1
KyusonLim
 
Lect w2 measures_of_location_and_spread
Lect w2 measures_of_location_and_spreadLect w2 measures_of_location_and_spread
Lect w2 measures_of_location_and_spread
Rione Drevale
 
Discretization of a Mathematical Model for Tumor-Immune System Interaction wi...
Discretization of a Mathematical Model for Tumor-Immune System Interaction wi...Discretization of a Mathematical Model for Tumor-Immune System Interaction wi...
Discretization of a Mathematical Model for Tumor-Immune System Interaction wi...
mathsjournal
 
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
mathsjournal
 
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
mathsjournal
 
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
mathsjournal
 
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
mathsjournal
 
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
mathsjournal
 
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
mathsjournal
 
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
mathsjournal
 

Similar to A041030106 (20)

Statistical analysis by iswar
Statistical analysis by iswarStatistical analysis by iswar
Statistical analysis by iswar
 
E45021924
E45021924E45021924
E45021924
 
Taller 2
Taller 2Taller 2
Taller 2
 
Use Proportional Hazards Regression Method To Analyze The Survival of Patient...
Use Proportional Hazards Regression Method To Analyze The Survival of Patient...Use Proportional Hazards Regression Method To Analyze The Survival of Patient...
Use Proportional Hazards Regression Method To Analyze The Survival of Patient...
 
Matching Weights to Simultaneously Compare Three Treatment Groups: a Simulati...
Matching Weights to Simultaneously Compare Three Treatment Groups: a Simulati...Matching Weights to Simultaneously Compare Three Treatment Groups: a Simulati...
Matching Weights to Simultaneously Compare Three Treatment Groups: a Simulati...
 
Computational Pool-Testing with Retesting Strategy
Computational Pool-Testing with Retesting StrategyComputational Pool-Testing with Retesting Strategy
Computational Pool-Testing with Retesting Strategy
 
Bayesian inference for mixed-effects models driven by SDEs and other stochast...
Bayesian inference for mixed-effects models driven by SDEs and other stochast...Bayesian inference for mixed-effects models driven by SDEs and other stochast...
Bayesian inference for mixed-effects models driven by SDEs and other stochast...
 
Fv3410771081
Fv3410771081Fv3410771081
Fv3410771081
 
3 es timation-of_parameters[1]
3 es timation-of_parameters[1]3 es timation-of_parameters[1]
3 es timation-of_parameters[1]
 
Causal Inference Opening Workshop - Some Applications of Reinforcement Learni...
Causal Inference Opening Workshop - Some Applications of Reinforcement Learni...Causal Inference Opening Workshop - Some Applications of Reinforcement Learni...
Causal Inference Opening Workshop - Some Applications of Reinforcement Learni...
 
Survival analysis 1
Survival analysis 1Survival analysis 1
Survival analysis 1
 
Lect w2 measures_of_location_and_spread
Lect w2 measures_of_location_and_spreadLect w2 measures_of_location_and_spread
Lect w2 measures_of_location_and_spread
 
Discretization of a Mathematical Model for Tumor-Immune System Interaction wi...
Discretization of a Mathematical Model for Tumor-Immune System Interaction wi...Discretization of a Mathematical Model for Tumor-Immune System Interaction wi...
Discretization of a Mathematical Model for Tumor-Immune System Interaction wi...
 
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
 
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
 
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
 
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
 
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
 
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
 
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
DISCRETIZATION OF A MATHEMATICAL MODEL FOR TUMOR-IMMUNE SYSTEM INTERACTION WI...
 

More from IOSR-JEN

C05921721
C05921721C05921721
C05921721
IOSR-JEN
 
B05921016
B05921016B05921016
B05921016
IOSR-JEN
 
A05920109
A05920109A05920109
A05920109
IOSR-JEN
 
J05915457
J05915457J05915457
J05915457
IOSR-JEN
 
I05914153
I05914153I05914153
I05914153
IOSR-JEN
 
H05913540
H05913540H05913540
H05913540
IOSR-JEN
 
G05913234
G05913234G05913234
G05913234
IOSR-JEN
 
F05912731
F05912731F05912731
F05912731
IOSR-JEN
 
E05912226
E05912226E05912226
E05912226
IOSR-JEN
 
D05911621
D05911621D05911621
D05911621
IOSR-JEN
 
C05911315
C05911315C05911315
C05911315
IOSR-JEN
 
B05910712
B05910712B05910712
B05910712
IOSR-JEN
 
A05910106
A05910106A05910106
A05910106
IOSR-JEN
 
B05840510
B05840510B05840510
B05840510
IOSR-JEN
 
I05844759
I05844759I05844759
I05844759
IOSR-JEN
 
H05844346
H05844346H05844346
H05844346
IOSR-JEN
 
G05843942
G05843942G05843942
G05843942
IOSR-JEN
 
F05843238
F05843238F05843238
F05843238
IOSR-JEN
 
E05842831
E05842831E05842831
E05842831
IOSR-JEN
 
D05842227
D05842227D05842227
D05842227
IOSR-JEN
 

More from IOSR-JEN (20)

C05921721
C05921721C05921721
C05921721
 
B05921016
B05921016B05921016
B05921016
 
A05920109
A05920109A05920109
A05920109
 
J05915457
J05915457J05915457
J05915457
 
I05914153
I05914153I05914153
I05914153
 
H05913540
H05913540H05913540
H05913540
 
G05913234
G05913234G05913234
G05913234
 
F05912731
F05912731F05912731
F05912731
 
E05912226
E05912226E05912226
E05912226
 
D05911621
D05911621D05911621
D05911621
 
C05911315
C05911315C05911315
C05911315
 
B05910712
B05910712B05910712
B05910712
 
A05910106
A05910106A05910106
A05910106
 
B05840510
B05840510B05840510
B05840510
 
I05844759
I05844759I05844759
I05844759
 
H05844346
H05844346H05844346
H05844346
 
G05843942
G05843942G05843942
G05843942
 
F05843238
F05843238F05843238
F05843238
 
E05842831
E05842831E05842831
E05842831
 
D05842227
D05842227D05842227
D05842227
 

Recently uploaded

IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptxIOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
Abida Shariff
 
ODC, Data Fabric and Architecture User Group
ODC, Data Fabric and Architecture User GroupODC, Data Fabric and Architecture User Group
ODC, Data Fabric and Architecture User Group
CatarinaPereira64715
 
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdfFIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance
 
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Tobias Schneck
 
Accelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish CachingAccelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish Caching
Thijs Feryn
 
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Product School
 
PHP Frameworks: I want to break free (IPC Berlin 2024)
PHP Frameworks: I want to break free (IPC Berlin 2024)PHP Frameworks: I want to break free (IPC Berlin 2024)
PHP Frameworks: I want to break free (IPC Berlin 2024)
Ralf Eggert
 
Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........
Alison B. Lowndes
 
Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*
Frank van Harmelen
 
"Impact of front-end architecture on development cost", Viktor Turskyi
"Impact of front-end architecture on development cost", Viktor Turskyi"Impact of front-end architecture on development cost", Viktor Turskyi
"Impact of front-end architecture on development cost", Viktor Turskyi
Fwdays
 
GraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge GraphGraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge Graph
Guy Korland
 
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdfFIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
BookNet Canada
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
ThousandEyes
 
To Graph or Not to Graph Knowledge Graph Architectures and LLMs
To Graph or Not to Graph Knowledge Graph Architectures and LLMsTo Graph or Not to Graph Knowledge Graph Architectures and LLMs
To Graph or Not to Graph Knowledge Graph Architectures and LLMs
Paul Groth
 
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Jeffrey Haguewood
 
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
UiPathCommunity
 
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
Prayukth K V
 
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
Sri Ambati
 
Knowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and backKnowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and back
Elena Simperl
 

Recently uploaded (20)

IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptxIOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
 
ODC, Data Fabric and Architecture User Group
ODC, Data Fabric and Architecture User GroupODC, Data Fabric and Architecture User Group
ODC, Data Fabric and Architecture User Group
 
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdfFIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
 
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
 
Accelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish CachingAccelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish Caching
 
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
 
PHP Frameworks: I want to break free (IPC Berlin 2024)
PHP Frameworks: I want to break free (IPC Berlin 2024)PHP Frameworks: I want to break free (IPC Berlin 2024)
PHP Frameworks: I want to break free (IPC Berlin 2024)
 
Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........
 
Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*
 
"Impact of front-end architecture on development cost", Viktor Turskyi
"Impact of front-end architecture on development cost", Viktor Turskyi"Impact of front-end architecture on development cost", Viktor Turskyi
"Impact of front-end architecture on development cost", Viktor Turskyi
 
GraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge GraphGraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge Graph
 
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdfFIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdf
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
 
To Graph or Not to Graph Knowledge Graph Architectures and LLMs
To Graph or Not to Graph Knowledge Graph Architectures and LLMsTo Graph or Not to Graph Knowledge Graph Architectures and LLMs
To Graph or Not to Graph Knowledge Graph Architectures and LLMs
 
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
 
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
 
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
 
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
 
Knowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and backKnowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and back
 

A041030106

  • 1. IOSR Journal of Engineering (IOSRJEN) www.iosrjen.org ISSN (e): 2250-3021, ISSN (p): 2278-8719 Vol. 04, Issue 10 (October. 2014), ||V3|| PP 01-06 International organization of Scientific Research 1 | P a g e Mathematical model for Oxytocin alleviates the neuroendocrine in healthy men S.Lakshmi* and M.Gayathri** *Principal, Government Arts & Science College, Peravurani – 614804, Thanjavur – Dt, Tamilnadu. **Research Scholar, P.G and Research Department of Mathematics, K.N. Govt. Arts College for Women (Autonomous), Thanjavur – 613007, Tamilnadu. Abstract: - Maximum Likelihood Estimation is by far the most popular method of parameter estimation and is an indispensable tool for many statistical modeling techniques, in particular in non-linear modeling with non- normal data. The purpose of this paper is to provide a good conceptual explanation of the method with illustrative examples. In application part by using normal distribution the likelihood functions for inflammatory hormone levels in response to endotoxin and plasma concentration oxytocin, ACTH, cortisol, and procalcitonin are obtained. These functions show a clear picture for all the above parameters when LPS+Oxytocin is administered to the inflammatory cases and compared with the medical conclusion. Keywords: Normal distribution, density function, oxytocin. Mathematical subject classification: 60GXX, 62HXX, 62PXX. 1.Mathematical model: I. INTRODUCTION In the psychological sciences, uncover general laws and principles that govern the behavior under investigation. As these principles are not directly observable, they are formulated in terms of hypotheses. In mathematical modeling, such hypotheses about the structure and inner working of the behavioral process of interest are stated in terms of mathematical functions called models. The goal of modeling is to deduce the form of the underlying process by testing the viability of such models. Once a model is specified with its parameters, data have been collected with specific norms. There are two generally accepted methods of parameter estimation. They are least-squares estimation (LSE) and maximum likelihood estimation (MLE). The former is well known to us as many of the familiar concepts such as linear regression, the sum of squares error, the proportion variance accounted[2] , and the root mean squared deviation are tied to the method. On the other hand, MLE is not widely recognized among modelers in psychology[3], though it is, by far, the most commonly used method of parameter estimation[7]. LSE might be useful for obtaining a descriptive measure for the purpose of summarizing observed data[9], but MLE is more suitable for statistical inference such as model comparison LSE has no basis for constructing confidence intervals or testing hypotheses. 1.2.Maximum Likelihood Estimation The likelihood Function Let X1,……Xn be an i.i.d sample with probability density function (p.d.f) f(xi;θ), where θ is a (k×1) vector of parameters that characterize f(xi;θ)[8]. For example, if Xi~ N(μ,휎2) then f(xi,θ) = (2π휎2)-1/2exp(- 12휎2( xi -μ)2) and θ = (μ,휎2 )ʹ. Then joint density of the sample is, by independence, equal to the product of the marginal densities f(x1,……..xn;θ) = f(x1;θ)……..f(xn;θ) = 푓푛푖 =1(xi,θ). The joint density is an n dimensional function of the data x1……..,xn given the parameter vector θ. The joint density satisfies f(x1,............xn;θ) ≥ 0 ∫…….∫ f(x1…………xn;θ) = 1. The likelihood function is defined as the joint density treated as a functions of the parameters θ : L(θ/x1,……..,xn) = f(x1,………xn;θ) = 푓푛푖 =1(xi,θ). Notice that the likelihood function is a k dimensional function of θ given the data x1,…..xn. It is important to keep in mind that the likelihood function, being a function of θ and not the data, is not a proper p.d.f .It is always positive but ∫……..∫ L(θ/x1……..xn)dθ1………dθk ≠ 1. To simplify notation, let the vector X = (x1,……..xn) denote the observed sample. Then the joint p.d.f and likelihood function may be expressed as f(X;θ) and L(θ/X).
  • 2. Mathematical model for Oxytocin alleviates the neuroendocrine in healthy men International organization of Scientific Research 2 | P a g e Example 1 Bernoulli Sampling Let Xi ̴ Bernoulli(θ). That is, Xi = 1 with probability θ and Xi = 0 with probability 1 – θ where 0 ≤ θ ≤ 1. The p.d.f for Xi is xi f(xi;θ) = 휃푥푖 (1−휃)1−푥푖, xi = 0,1 Let X1,…..Xn be an iid sample with Xi ̴ Bernoulli(θ).The joint density/ likelihood function is given by f(x;θ) = L(θ/x) = 휃푥푖푛푖 =1(1−휃)1−푥푖 = 휃 푥푖 푛푖 =1(1−휃)푛− 푥푖 푛푖 =1 For a given value of θ and observed sample x, f(x,θ) gives the probability of observing the sample. For example, suppose n=5 and x = (0,…..,0). Now some values of θ are more likely to have generated this sample than others. In particular, it is more likely that θ is close to zero than one. To see this, note that the likelihood function for this sample is L(θ/(0,…….,0)) = (1-θ)5 The likelihood function has a clear maximum at θ = 0. That is, θ = 0 is the value of θ that makes the observed sample x = (0,……,0) most likely (highest probability) Similarly, suppose x = (1,……..,1). Then the likelihood function is L(θ/(1,……,1)) = θ5 Now the likelihood function has a maximum at θ = 1. Example 2 Normal Sampling Let X1,……….,Xn be an iid sample with Xi ̴ N(μ,휎2). The pdf for Xi is f(xi;θ) = (2π휎2)-1/2exp (- 12휎2 (xi-μ)2), - ∞<휇<∞, 휎2>0, -∞<푥<∞ so that θ = (μ,휎2)ʹ. The likelihood function is given by L(θ/x) = (푛푖 =12π휎2)-1/2exp (- 12휎2 (xi-μ)2), = (2π휎2)-n/2exp (- 12휎2 (푥푛푖 =1i-μ)2) Suppose 휎2 = 1. Then L(θ/x) = L(μ/x) = (2휋)-n/2exp(- 12 (푥푛푖 =1i-μ)2) Now (푥푛푖 =1i-μ)2 = (푥푛푖 =1i - 푥 +푥 -μ)2 = [(푥푛푖 =1i-푥 )2 + 2(xi-푥 )(x-휇 ) + (푥 -μ)2] = (푥푛푖 =1i-푥 )2 + n(푥 -μ)2 So that L(μ/x) = (2π)-n/2exp( - 12 [ (푛푖 =1xi-푥 )2 + n(푥 -μ)2] ) Since both (xi-푥 )2 and (푥 -μ)2 are positive it is clear that L(μ/x) is maximized at μ =푥 . II. APPLICATION Oxytocin is a hormone and neurotransmitter found to have anti- inflammatory functions in rodents. Ten healthy men received , in a randomized, placebo controlled crossover design, placebo, oxytocin, LPS, and LPS+oxytocin. Oxytocin treatment resultedin a transient or prolonged reduction of endotoxin-induced increase in plasma ACTH, Cortisol, prolactionin.Oxytocin decreases the neuroendocrine and cytokine activation caused by bacterial endotoxin in men. Possibly due to the pathway. Oxytocin –deficient mice exhibit increased stress response associated with a significant hyperactivation of the HPA axis[6]. Here we present a randomized, placebo-controlled, crossover trial, conducted to test the effect of continuous intravenous oxytocin infusion on LPS-induced systemic inflammation in 10 healthy men. In addition, we investigated whether oxytocin directly affects the LPS-induced cytokine release from peripheral blood mononuclear cells (PBMCs) of healthy human donors in vitro. 2.1.Hormone and cytokine measurement. Blood samples were immediately cooled and centrifuged for 10 min at 3.000 rpm, 4ºC, and plasma aliquots were immediately frozen at -20ºC. Plasma oxytocin and ACTH were measured using commercial RIA kits Procalcitonin (PCT) was measured using the BRAHMS Procalcitonin Sensitive LIA kit[5]. All samples taken over the 4 study days for each individual subject were analyzed at the same time and in duplicates. Cell isolation and culture. PBMCs were isolated from acid citrate dextrose buffy coats of healthy donors. CD14_ monocytes were obtained by magnetic cell sorting using anti-CD14-conjugated magnetic microbeads CD14_ monocytes (2 ± 106) or PBMCs (106 cells/ml) were cultured in human serum albumin-containing X- Vivo 10 medium in 12-well plates for 2, 4, and 24 h. Different concentrations of oxytocin (Sigma) or vehicle control (0.1% water) were added to the cells 30 min before adding LPS.
  • 3. Mathematical model for Oxytocin alleviates the neuroendocrine in healthy men International organization of Scientific Research 3 | P a g e 2.2. Hormone Response Administration of oxytocin elevated within 10 min plasma oxytocin levels (P = 0.021), which reached peak values at time point 60 min (P <0.001) (Fig. 2.2 A). Circulating oxytocin then began to decline 10 min after the infusion was stopped, but remained significantly elevated until time point 120 min (P < 0.001) (Fig. 2.2.A). Plasma concentrations of ACTH (Fig. 2.2.B) and cortisol (Fig. 2.2.C) remained unchanged during oxytocin treatment, but increased after the LPS bolus (P = 0.027 for ACTH at 120 min and P = 0.043 for cortisol at 90 min when comparing LPS vs. placebo). A significantly reduced increase in plasma ACTH was observed at time point 120 min: 36.1 ± 5.9 pg/ml in the LPS ± oxytocin group vs.69.6 ± 14.8 pg/ml in the LPS group (P = 0.019) (Fig. 2.2.B). The LPS-induced increase in plasma cortisol was also alleviated in the LPS ±oxytocin group at time points 90 min (P = 0.03) and 120 min (P = 0.01) (Fig. 2.2.C). To further evaluate the impact of oxytocin on the severity of endotoxinemia, measured the plasma concentrations of PCT, a diagnostic and prognostic biomarker in sepsis [10] Oxytocin significantly reduced the LPS-induced increase in PCT, which presented significant differences at the 240th min (0.178 ± 0.05 ng/ml on LPS days compared with 0.072 ± 0.01 ng/ml on LPS ± oxytocin days, P = 0.043), at the 300th min (P = 0.033), and at the 360th min (P = 0.035) (Fig. 2.3). Consideration the possibility that repeated injections of endotoxin itself may result in an altered immune response, inducing resistance or tolerance in humans. Therefore, the subjects received the four treatments in a randomized order. In addition, we compared the changes in plasma ACTH, cortisol, and PCT between volunteers randomized to receive LPS before the application of LPS ± oxytocin (n = 5) and volunteers randomized to receive LPS ±oxytocin before the administration of LPS (n = 5). Results were similar to those obtained from all volunteers being treated with LPS vs. all volunteers having received LPS ±oxytocin. Figure 2.2. Hormone levels in response to endotoxin and oxytocin. Plasma concentrations are shown of oxytocin (A), ACTH (B),and cortisol (C) in response to placebo, oxytocin (1pmol kg -1 min-1 during 90 min. 1=- 10 to 80 min). LPS (2ng/kg iv. i =0 h), and LPS+oxytocin values are means ± SE.
  • 4. Mathematical model for Oxytocin alleviates the neuroendocrine in healthy men International organization of Scientific Research 4 | P a g e Figure 2.3.Procalcitonin (PCT) levels in response to endotoxin and oxytocin. Plasma PCT concentrations are shown after placebo or LPS administration (2ng/kg iv. i=0 h), in the presence or absence of oxytocin infusion (t= -10 to 80 min). Values are means ± SE. First, the study population included only healthy men, and we have no data on the role of oxytocin on the LPS-induced endocrine and cytokine activation in women[1]. Second, as this is the first study coadministrating LPS and oxytocin in humans, we took care to use the smallest oxytocin dose needed to achieve elevated oxytocin concentrations during the first 120 min after LPS administration. Nevertheless, the achieved maximal concentrations of 160–180 pg/ml are clearly supraphysiological. Third, LPS administration is only an experimental and self-limiting model of infection and inflammation. In summary, this study demonstrates that pharmacological doses of oxytocin attenuate the endocrine and cytokine activation following bacterial endotoxin administration in humans. Oxytocin appears to modulate innate host defense mechanisms, thereby eventually reducing an LPS-induced overshooting immune response. Mathematical Results A. 0 0.5 1 1.5 2 2.5 3 3.5 1 2 3 4 5 6 7 8 9 10 11 12 13 L(θ/x) x Time (1 Unit=30min) Likelihood function for oxytocin (pg/ml) LPS+oxytocin oxytocin Placebo LPS
  • 5. Mathematical model for Oxytocin alleviates the neuroendocrine in healthy men International organization of Scientific Research 5 | P a g e B. C. D. Figure (3.1) 0 0.2 0.4 0.6 0.8 1 1 2 3 4 5 6 7 8 9 10 11 12 13 L(θ/x) x Time (1 Unit=30min) Likelihood functionfor ACTH (pg/ml) LPS Placebo oxytocin LPS+oxytocin 0 0.5 1 1.5 2 2.5 3 3.5 4 1 2 3 4 5 6 7 8 9 10 11 12 13 L(θ/x) x Time(1 unit =30 min) Likelihood function for cortisol (pg/ml) LPS LPS+oxytocin oxytocin Placebo -0.2 0 0.2 0.4 0.6 0.8 1 1.2 0 5 10 15 L(θ/x) x Time (1unit=30 min) Likelihood function for PCT (mg/ml) oxytocin LPS+oxytocin LPS
  • 6. Mathematical model for Oxytocin alleviates the neuroendocrine in healthy men International organization of Scientific Research 6 | P a g e The figure (3.1),A. indicates that the likelyhood function for oxytocin (pg/ml) is suddenly decreased when LPS+oxytocin is administered. In both the cases the curves are continuous and decreased monotonically with the time axis. Similarly we have obtained the curves for the likelyhood functions for all other categories like ACTH, Cortisol, PCT (if we compare LPS administration cases). These results can be compared with the medical conclusions. This study demonstrates that pharmacological doses of oxytocin attenuate the endocrine and cytokine activation following endotoxin administration in humans. Oxytocin appears to modulate innate host defense mechanism, thereby eventually reducing an LPS induced overshooting immune response. CONCLUSION Maximum Likelihood Estimation is by far the most popular method of parameter estimation and is an indispensable tool for many statistical modeling techniques, in particular in non-linear modeling with non- normal data[4]. The purpose of this paper is to provide a good conceptual explanation of the method with illustrative examples. In application part by using normal distribution the likelihood functions for inflammatory hormone levels in response to endotoxin and plasma concentration oxytocin, ACTH, cortisol, and procalcitonin[10] are obtained. These functions show a clear picture for all the above parameters when LPS+Oxytocin is administered to the inflammatory cases and compared with the medical conclusion. This study demonstrates that pharcological doses of oxytocin attenuate the endocrine and cytokine activation following endotoxin administration in humans. Oxytocin appears to modulate innate host defense mechanism, thereby eventually reducing an LPS induced overshooting immune response. The figure (3.1),A. indicates that the likelyhood function for oxytocin (pg/ml) is suddenly decreased when LPS+oxytocin is administered. In both the cases the curves are continuous and decreased monotonically with the time axis. Similarly we have obtained the curves for the likelyhood functions for all other categories like ACTH, Cortisol, PCT (if we compare LPS administration cases). REFERENCES [1] Amico JA, Mantella RC, Wollmer RR, Li X. Anxiety and stress responses in female oxytocin deficient mice. J Neuroendocrinol 16:319–324, 2004 [2] Bain L.J., Statistical Analysis of Reliability and life testing models ,Marcel Dekker, New York, 1978 [3] Cohen, A.C.,Jr., Tables for Maximum likelihood estimates; singly truncated and single censored s samples, Technometrices, 3:535-541(1961). [4] Consul PC, Shenton LR, Some interesting properties of Lagrangian distributions. Comm. Stat. Theor. Meth: 2, 3, 263 – 272, 1973. [5] Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 34: 2596– 2602, 2006. [6] Kiriyama Y, Nomura Y, Tokumitsu Y. Calcitonin gene expression induced by lipopolysaccharide in the rat pituitary. Am J Physiol Endocrinol Metab 282: E1380–E1384, 2002. [7] Lakshmi S, Gayathri M, Mathematical model for roles of Genital stumilation, intracerebral Oxytocin release. American Journal of pure and applied mathematics. Vol 2, No 2, July-December 2013, 93-98. [8] Le Cam, Lucien; Lo Yang, Grace (2000). Asymptotics in Statistics: Some Basic Concepts (second ed.). Springer. ISBN 0-387-95036-2. [9] Pfanzagl, Johann (1994). Parametric statistical theory. with the assistance of R. Hamböker. Berlin, DE: Walter de Gruyter. pp. 207–208.ISBN 3-11-013863-8 [10] Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for Med sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care34: 1996–2003, 2006.